Skip to content

Generate Biomedicines, Inc. GENB Finance Lease Liability, Current

Finance Lease Liability, Current at other companies

MYR Group logo
MYR GroupMYRG
$799K-14.8%
SSR Mining logo
SSR MiningSSRM
$91K-98.1%
ST
Sensata TechnologiesST
$2.4M+12.7%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$1.7M+9.1%
BOB
Bob's Discount Furniture BOBS
$14.23M
Boot Barn Holdings logo
Boot Barn HoldingsBOOT
$1.03M+8.3%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's finance lease liability, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's finance lease liability, current?
Generate Biomedicines, Inc. (GENB) reported finance lease liability, current of $3.88M in Q1 2026.
What does finance lease liability, current mean?
Finance lease liabilities (current) represent the portion of lease obligations that are due to be paid within the next twelve months. These obligations arise from long-term contracts where the company effectively controls the leased asset. This metric is critical for assessing near-term liquidity and cash flow requirements.